Amid growing worries about the quality of medicines in India, the government is planning a big shake-up in how drug marketers are controlled. The drug regulator wants to make sure no medicine is sold or marketed without a proper license. Right now, the law says marketers are responsible for drug quality, but there is no strict check on their activities. A recent government document reveals plans to change the Drugs and Cosmetics Rules. These changes will make it mandatory for drug marketers to get a license before they can sell medicines. The idea is simple: license first, sell later! This will help the authorities keep a close eye on marketers and make sure only safe and effective medicines reach consumers. The document points out that often drug marketers don’t share clear contact details or company information, making it hard for regulators to reach them. "Provisions need to be included in the rules, requiring that no marketer shall market any drug without license obtained from the licensing authority," the document states clearly. This rule will shake up the pharmaceutical world, including many Indian and global companies that market medicines made by others. Some industry experts cheer this move, saying it will block fake and low-quality medicines. But others worry it might slow down business, hitting both small and big players. Back in 2018, India’s top drug advisory body already approved the idea to make drug marketing firms answerable if they break any rules. Now, the government seems ready to make it official and tough. So, is this the start of a drug quality revolution in India? Will new licenses put an end to spurious drugs flooding the market? One thing is clear – the days of free-for-all medicine marketing might soon be over!